Evidence map›Paper›PMID 39330184›Full record

ArticleGels (Basel, Switzerland)2024

Development and Investigation of a Nanoemulgel Formulated from Tunisian

Badr Bahloul, Enis Ben Bnina, Dorra Dridi, Aya Bouhamed, Luis Castillo Henríquez, Guido Flamini, José Roberto Vega-Baudrit

Abstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Badr BahloulDrug Development Laboratory LR12ES09, Faculty of Pharmacy, University of Monastir, Monastir 5000, Tunisia.ORCID 0000-0001-7512-1331
Enis Ben BninaLR21AGR03-Production and Protection for a Sustainable Horticulture (2PHD), IRESA-University of Sousse, Regional Research Centre on Horticulture and Organic Agriculture, Sousse 4042, Tunisia.
Dorra DridiDrug Development Laboratory LR12ES09, Faculty of Pharmacy, University of Monastir, Monastir 5000, Tunisia.ORCID 0009-0004-3176-7332
Aya BouhamedDrug Development Laboratory LR12ES09, Faculty of Pharmacy, University of Monastir, Monastir 5000, Tunisia.
Luis Castillo HenríquezCNRS, INSERM, UTCBS, Chemical and Biological Technologies for Health Laboratory, Université Paris Cité, F-75006 Paris, France.ORCID 0000-0001-5276-4772
Guido FlaminiDipartimento di Farmacia, Via Bonanno 6, 56126 Pisa, Italy.ORCID 0000-0003-2418-9349
José Roberto Vega-BaudritNational Nanotechnology Laboratory (LANOTEC), National Center for High Technology (CeNAT), San José 1174-1200, Costa Rica.ORCID 0000-0002-2002-1744

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study is to develop a nanoemulgel encapsulating a Tunisian Prickly Pear (

Indexed as

advanced gelsgas chromatographynanoemulsionOpuntia ficus-indica L.pharmaceutical nanotechnologyphytotherapytopical delivery

Identifiers

PMID39330184
PMCPMC11431070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.